The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

PURPOSE: To determine the incidence of chemotherapy-induced nausea/vomiting (CINV) and chemotherapy treatment delay and adherence among patients receiving palonosetron versus other 5-hydroxytryptamine receptor antagonist (5-HT(3) RA) antiemetics. MATERIALS AND METHODS: This retrospective claims anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Palli, Swetha Rao, Grabner, Michael, Quimbo, Ralph A, Rugo, Hope S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476437/
https://www.ncbi.nlm.nih.gov/pubmed/26124681
http://dx.doi.org/10.2147/CMAR.S71355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476437/
https://www.ncbi.nlm.nih.gov/pubmed/26124681
http://dx.doi.org/10.2147/CMAR.S71355

Ejemplares similares